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Available online 27 July 2016As awidely-applied alternative therapy, acupuncture is gaining popularity inWestern society. One challenge that
remains, however, is incorporating it into mainstream medicine. One solution is to combine acupuncture with
other conventional,mainstream treatments. In this study, we investigated the combination effect of acupuncture
and the antidepressantﬂuoxetine, aswell as its underlyingmechanismusing resting state functional connectivity
(rsFC) in patients with major depressive disorders.
Forty-six female depressed patients were randomized into a verum acupuncture plus ﬂuoxetine or a sham acu-
puncture plus ﬂuoxetine group for eight weeks. Resting-state fMRI data was collected before the ﬁrst and last
treatments. Results showed that compared with those in the sham acupuncture treatment, verum acupuncture
treatment patients showed 1) greater clinical improvement as indicated by Montgomery–Åsberg Depression
Rating Scale (MADRS) and Self-Rating Depression Scale (SDS) scores; 2) increased rsFC between the left amyg-
dala and subgenual anterior cingulate cortex (sgACC)/preguenual anterior cingulate cortex (pgACC); 3) in-
creased rsFC between the right amygdala and left parahippocampus (Para)/putamen (Pu). The strength of the
amygdala-sgACC/pgACC rsFC was positively associated with corresponding clinical improvement (as indicated
by a negative correlation with MADRS and SDS scores). Our ﬁndings demonstrate the additive effect of acupunc-
ture to antidepressant treatment and suggest that this effect may be achieved through the limbic system, espe-
cially the amygdala and the ACC.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Combination effect1. Introduction
Major depressive disorder (MDD) is a common disorder that affects
a large proportion of the population by signiﬁcantly impairing their oc-
cupational, social, and academic functioning (Johnson et al., 1992;
Lehtinen & Joukamaa, 1994). Current treatments of antidepressant
medications may be provided as an initial primary treatment for MDD,
but they are far from satisfactory (Rush et al., 2003; Sackeim, 2001)
due to undesirable side effects and a delay in the onset of therapeutic ac-
tion (Arroll et al., 2005; Zhu et al., 2013).raditional Chinese Medicine of
assachusetts General Hospital,
nmr.mgh.harvard.edu (J. Kong).
. This is an open access article underIn recent years, acupuncture has become a promising and effective
alternative treatment for depression (Jorm et al., 2002; Kessler et al.,
2001; Im. Quah-Smith et al., 2013; Im. Quah-Smith et al., 2012). Studies
suggest that acupuncture may work by inducing the release of norepi-
nephrine, serotonin, and dopamine in the central nervous system
(Siedentopf, 2005; Ulett, 1998), all of which play a role in the patho-
physiology of MDD (Belmaker & Agam, 2008).
As a popular alternative and complementary modality, acupuncture
is gaining popularity in Western society. One challenge that remains,
however, is incorporating it into mainstream medicine. One solution is
to combine acupuncture with other conventional, mainstream treat-
ments. Using the treatment of depression as an example, accumulating
evidence has indicated that acupuncture combinedwith antidepressant
medications is more effective than antidepressants alone, safe, well-tol-
erated, and has an early onset of action (Zhang et al., 2009; Zhu et al.,
2013) However, the lack of understanding regarding the underlying
mechanisms of the combinative treatment of acupuncture andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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corporate this treatment into mainstreammedicine.
In recent years, brain imaging techniques have been applied to in-
vestigate the physiopathology of depression and revealed that MDD is
associated with structural and functional abnormalities in brain circuits
involved in emotional processing, self-representation, reward, and ex-
ternal stimulus (stress, distress) interactions (Davidson et al., 2002;
Hasler & Northoff, 2011;Lu et al., 2012; Mwangi et al., 2012; D. A.
Pizzagalli, 2011; Silbersweig, 2013). Many brain regions including the
amygdala, hippocampus, insula, ventral striatum, ventral anterior cin-
gulate gyrus, and prefrontal cortex are involved in the neural pathology
and development of MDD (Lawrence et al., 2004; Phillips et al., 2015;
Phillips et al., 2003a, 2003b) and subthreshold depression (Hwang et
al., 2016). Among these brain regions, one of the most well-studied re-
gions is the amygdala.
As part of the limbic system, the amygdala plays a vital role in emo-
tional processing, fear learning, and motivation behaviors (Adolphs et
al., 1994; Cardinal et al., 2002; Mears & Pollard, 2016; Phelps et al.,
2004; Phelps & LeDoux, 2005). Studies showed that compared with
healthy controls, MDD patients showed abnormal elevated activity in
the amygdala when presented with negative stimuli (Phillips et al.,
2015; Sheline et al., 2010; Siegle et al., 2002; Siegle et al., 2007). In a
more recent meta-analysis, Ma (Ma, 2015) found that antidepressant
medication in patients withmood disorders affects the amygdala by de-
creasing its activity during negative emotions and increasing its activity
during positive emotions.
Seed-based resting-state functional connectivity (rsFC) is a method
of functional brain imaging that can assess the temporal dependency
of brain regions (seeds) during rest (Biswal et al., 1995). rsFC allows
for the study of the function of one or several brain regions in relation
to its functional network and how the network contributes to brain pro-
cedures (Hwang et al., 2015; Jessica S. Damoiseaux & Greicius, 2009). It
has also widely been used to reveal the underlying mechanisms of dif-
ferent diseases (Sun et al., 2012; J. Wang et al., 2013a,c; Zheng et al.,
2014), including depression (L. Wang et al., 2013a,c; L. Wang et al.,
2015). Previous studies suggested that acupuncture can signiﬁcantly
modulate rsFC in healthy subjects (Bai et al., 2009; Dhond et al., 2008;
Hui et al., 2009; P. Liu et al., 2009; Qin et al., 2008; Zhong et al., 2012)
and patient populations, such as patients with knee osteoarthritis (X.
Chen et al., 2015; Egorova et al., 2015), migraine (Li et al., 2016a,b;
Zhao et al., 2014) and Alzheimer's disease (Z. Wang et al., 2014). Few
studies (Yi et al., 2012), however, have analyzed rsFC changes resulting
from repeated acupuncture treatments for MDD.
In this study, we investigated rsFC changes in the left and right
amygdala before and after verum acupuncture plus ﬂuoxetine and
sham acupuncture plus ﬂuoxetine in patients with MDD. Considering
that brain activity dysfunction may vary betweenmale and female sub-
jects (Altemus et al., 2014; Bangasser & Valentino, 2014), we only re-
cruited female patients to increase the homogeneity of this study. We
hypothesized that in contrast to sham acupuncture treatment, verum
acupuncture treatment can modulate amygdala-related rsFC. In addi-
tion, rsFC changes may be associated with changes in the depressive
symptoms of patients.
2. Materials and methods
2.1. Participants
The study protocol was approved by the Institutional Review Board
of the 2nd Afﬁliated Hospital of Guangzhou University of Chinese Med-
icine. The study was enrolled online on the Chinese Clinical Trial Regis-
try (ChiCTR) (www.chictr.org.cn, ChiCTR-TRC-14,005,228). All patients
were provided written informed consent before participation in the
study. PatientswithMDDwere recruited for this study through commu-
nity postings, and all eligible participants were required to meet the
speciﬁc inclusion/exclusion criteria.2.1.1. Inclusion criteria
1)Womenwhomet the criteria of depression in ICD-10; 2) standard
score of Self-Rating Depression Scale (SDS)≥ 53 or total score of Mont-
gomery-Asberg depression rating scale (MADRS) ≥ 14; 3) aged 30–
60 years old and able to provide voluntary informed consent; 4) right-
handed; 5) primary school education or higher; and 6) normal cognitive
functioning, with no aphasia or intellectual disabilities.
2.1.2. Exclusion criteria
1) Refused to sign informed content; 2) pregnant or lactatingwomen;
3) women with metallic implants; 4) used antipsychotics or antidepres-
santswithin amonth before the study; 5) consumption of alcohol or illicit
substances; 6) patients with severe damage of liver or kidney function, or
with neurological deﬁcits, rheumatologic disorders, cardiac disease, dia-
betes, malignant tumors or any other signiﬁcant systemic disorders that
might affect the results; 7) presence of severe psychoses (schizophrenia,
mania, paranoid psychosis or depression with suicidal intent) or demen-
tia; 8) presence of any somatic diseases (such as cerebral infarction, cere-
bral hemorrhage, Parkinson's or cerebral tumor) or any other signiﬁcant
systemic disorders that might affect the results.
2.2. Intervention
All participants received ﬂuoxetine (20mg po qd) once per day plus
verum or sham acupuncture treatment based on randomization.
2.3. Verum and sham acupuncture administration
In this study,we applied abdominal acupuncture, an acupuncturemo-
dality (Zhiyun, 2001) that has been proven to be effective for depression
(Cheng & Tang, 2007; Lyons et al., 2012; X. Y.Wang et al., 2010;Wu et al.,
2012). The advantage of abdominal acupuncture is that it only produces
mild sensations, possibly making it more acceptable to patients.
Abdominal acupuncture is based on the Chinese Traditional Medi-
cine theory that CV 8 (umbilicus) plays a crucial role in propelling and
regulating the ﬂow of Qi (Zhiyun, 2001). Abdominal acupuncture uses
only acupoints in the abdomen because these acupoints are close to im-
portantmeridians and can easily communicatewith ﬁve zang and six fu
organs through channels like Conceptional Vessel, Governor Vessel,
Thoroughfare Meridian and Belt Meridian. Based on a previous study
from our group (X. Y. Wang et al., 2008), the acupoints applied in this
studywere: Zhongwan (RN12), Xiawan (RN10), Qihai (RN6), Guanyuan
(RN4), Shangqu (KL17), Huaroumen (ST24), and Qipang (extra-point)
(Fig. 1). This prescription could harmonize zang-fu ﬁve viscera, tonify
qi, and replenish blood to relieve depression. An acupuncturist with
N3 years of experience performed all acupuncture treatments.
Before acupuncture administration, each participant was asked to lie
in a supine position and to wear a mask over her eyes. Then, the
participant's abdomen was exposed and the skin was disinfected at
the acupuncture points. Afterwards, an acupuncture specialist inserted
ﬁne needles (0.22mm×40mm) through short plastic tubes or sheaths.
The needles were inserted intramuscularly to a depth of 15–20mmand
were left in situ for 20 min. The patient's abdomen was covered with a
basket underneath a sheet during the treatment period. Patients re-
ceived abdominal acupuncture once a day for the ﬁrst three days and
subsequently once every three days for the remainder of the 8-week
trial. We chose this paradigm so that the effect of acupuncture could
be accumulated quickly, enhancing the conﬁdence and compliance of
patients at the beginning of the study.
For shamacupuncture, the acupointswere the same as in the real acu-
puncture group. Before sham abdominal acupuncture administration,
each patient was asked to lie in a supine position and put a mask over
her eyes. Then, the subject's abdomen was exposed and the acupoint
areas were disinfected. Later, short plastic needle sheaths not containing
any needles were tapped against the skin of the patient’s acupoints, but
no needles were inserted into the skin through the sheaths. Then, as
Fig. 1. Locations of acupoints applied in this study.
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basket underneath a sheet during the ‘treatment’ period. The time and
frequency of the sham abdominal acupuncture treatments were exactly
the same as in the verum acupuncture group.
2.4. Clinical outcomes
MADRS and SDS were used to assess the clinical outcomes. Both
were evaluated at time points before the ﬁrst treatment and after the
ﬁnal treatment.
2.5. MRI data acquisition
The fMRI brain imaging acquisition was conducted on a 1.5 Tesla Sie-
mens AvantoMR scanner. T2*-weighted functional images encompassing
the whole brain were acquired with the gradient-echo EPI sequence
(echo time: 30 ms, repetition time: 2000 ms, data matrix: 64 × 64, ﬁeld
of view: 240 mm, ﬂip angle: 90°, slice thickness: 4 mm, interslice gap:
0.88 mm, 31 slices paralleled to the AC-PC line, and 180 time points ac-
quired in 6 min). Two 6-minute resting-state fMRI scans were applied
while the subjects were required to keep their eyes closed to relax the
mind but not to fall asleep and not to think of anything in particular.
High-resolution brain structural images were also acquired with a T1-
weighted three-dimensional multi-echo magnetization-prepared rapid
gradient-echo (MP-RAGE) sequence (repetition time: 1900 ms, echo
time: 2.3 ms, data matrix: 256 × 256, ﬁeld of view: 256 mm × 256 mm,
slice thickness 1 mm, ﬂip angle: 15°, and 176 sagittal slices covering the
whole brain).
2.6. Statistical analysis
2.6.1. Clinical data analysis
Statistical analysis was performed using SPSS 19.0 Software (SPSS Inc.,
Chicago, IL, USA). Two sample t-test was used to compare baselinemeasurements between groups, and analysis of covariance (ANCOVA)
was applied to compare MADRS and SDS scores before and after treat-
ments between groups. Age was included in the model to adjust for its
effects.
2.6.2. Resting-state fMRI data analysis
Functional data were preprocessed using SPM8 (Statistical Paramet-
ric Mapping. Welcome Department of Cognitive Neurology, London,
UK; implemented by MATLAB R2012b, Math Works, Inc., Natick, MA,
USA). During the preprocessing, images were realigned, segmented,
and co-registered to each subject's high-resolution T1 scan, which was
used in normalizing to the standard Montreal Neurological Institute
(MNI) template. Images were also smoothed using an 8 mm full-
width at half-maximum (FWHM) Gaussian kernel, ﬁltered with a fre-
quency window of 0.008–0.09 Hz. Subsequently, we segmented the
brain into gray matter, white matter, and cerebrospinal ﬂuid (CSF) for
the removal of temporal confounding factors (white matter and CSF)
(Whitﬁeld-Gabrieli & Nieto-Castanon, 2012). Finally, data were then
submitted to motion correction using the artifact detection toolbox
(http://www.nitrc.org/projects/artifact_detect/). Time points in sub-
jects' images were marked as outliers if the global signal exceeded
three standard deviations from the mean or if scan-to-scan motion
exceeded 0.5 mm deviation (Redcay et al., 2013).
Resting-state functional connectivity analysis was conducted using
the CONN toolbox v15.g (Whitﬁeld-Gabrieli & Nieto-Castanon, 2012)
(http://www.nitrc.org/projects/conn). Bilateral amygdala seeds were
generated from the AAL, (Rolls et al., 2002) using WFU-Pick Atlas soft-
ware (Maldjian et al., 2003) (Fig. 2a). Functional connectivity measures
were computed between a seed region of interest (ROI) and every other
voxel in the brain. In the calculations, we ﬁrst extracted the residual
BOLD time course from a given seed and then estimated its ﬁrst-level
correlation maps by computing Pearson’s correlation coefﬁcients be-
tween that time course and the time courses of all other voxels in the
brain. Correlation coefﬁcients were transformed into Fisher’s ‘Z’-scores,
Fig. 2. Amygdala seed locations and brain regions with signiﬁcant changes (post minus pre) of rsFC with the amygdala modulated by the verum acupuncture plus ﬂuoxetine compared
with sham acupuncture plus ﬂuoxetine treatment. Abbreviations: sgACC, subgenual anterior cingulate cortex; pgACC, pregenual anterior cingulate cortex; Para, parahippocampus; Pu,
Putamen.
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al Linear Model analyses.
Amygdala seed-to-voxel functional connectivity was estimated for
each subject. Between-group analyses were performed to compare the
rsFC change (post-treatment minus pre-treatment) between the two
groups. In the calculations, two sample t-tests were adopted and a
threshold of a voxel-wise p b 0.005 (uncorrected) and cluster-level
p b 0.05 family-wise error correction was applied.
3. Results
Of all forty-six subjects (22 in the verum group, 24 in the sham
group) who participated the study, 36 subjects (18 in the verum
group, 18 in the sham group) were scanned at week 0 and week 8. Six
subjects from the sham acupuncture group dropped out (2 due to dis-
comfort from treatment (headache and diarrhea), 1 due to a scheduling
conﬂict, and 3 due to having had only one scan), and four subjects from
the verum acupuncture group dropped out (3 due to having had only
one fMRI scan and 1 due to a scheduling conﬂict). Thus, all of the clinical
and imaging analyses were based on these 36 subjects.
No signiﬁcant differenceswere found between the two groups in age
(t(34) = 0.22, p = 0.83) and MADRS (F(1,33) = 0.01, p = 0.97) and SDS
(F(1,33) = 0.01, p = 0.94) scores at baseline (Table 1). ANCOVA analysis
revealed signiﬁcant differences in bothMADRS and SDS scores between
the verum acupuncture and sham acupuncture groups. The verum acu-
puncture group showed signiﬁcantly greater clinical improvement
(post minus pre-treatment, MADRS, F(1,33) = 10.86, p b 0.01; SDS, F
(1,33) = 8.21, p b 0.01) compared to sham acupuncture (Table 1).
3.1. Resting state functional connectivity results
Baseline analysis showed that there was no signiﬁcant rsFC differ-
ence between the two groups at baseline. After 8 weeks of treatment,
participants in the verum acupuncture group showed increased rsFC
at the left amygdala-subgenual anterior cingulate cortex (sgACC)/
pregeunal antieror cingulated cortex (pgACC) and right amygdala-Table 1
Demographic and Clinical Characteristics of participants in this study. Abbreviations: MADRS, M
Characteristic Conditions
No. of participants who completed the study
Age (years old)
MADRS Pre-treatment
Post-treatment
SDS Pre-treatment
Post-treatmentparaphippocampus (Para)/putman (Pu) compared to baseline (Table
2). The sham acupuncture plus ﬂuoxetine group showed decreased
rsFC between the right amygdala-left Para/Pu after eightweeks of treat-
ment (Table 2).
We also compared the increased rsFC (post-treatment minus pre-
treatment) between the two groups. The results showed that the
verum group showed signiﬁcantly increased rsFC between the left
amygdala and left sgACC/pgACC (Table 2, Fig. 2b) compared to the
sham acupuncture group. The right amygdala showed signiﬁcantly in-
creased rsFC with the left Para/Pu (Table 2, Fig. 2c) in the verum acu-
puncture group compared to the sham acupuncture group.
To explore the association between rsFC and each of the correspond-
ing clinical outcomes, we extracted the Fisher ‘Z’ value (a sphere of
3 mm radius around the peak voxel) of the left sgACC/pgACC and the
Pu/Para, and then applied a multiple regression analysis controlling
for the age effect across all participants. The results showed that the in-
crease of rsFC between the left amygdala and sgACC/pgACC was signif-
icantly negatively associated with MADRS (p = 0.02, FDR corrected)
and SDS (p = 0.01, FDR corrected) scores across all subjects.4. Discussion
In this study, we investigated amygdala-related rsFC changes before
and after eight weeks of acupuncture plus ﬂuoxetine treatment as com-
pared with sham acupuncture plus ﬂuoxetine in female depressive dis-
order patients. Our results revealed a signiﬁcant remission of depressive
symptoms in the verum acupuncture plus ﬂuoxetine group compared
with the control group. In addition, we also found that verum acupunc-
ture plus ﬂuoxetine treatment can signiﬁcantly increase the rsFC of the
amygdala with brain regions associated with emotion and affect modu-
lation. The rsFC changes in the amygdala were also signiﬁcantly associ-
ated with a reduction in symptom severity as indicated by MADRS and
SDS scores, implying that acupuncture plus ﬂuoxetine treatment may
achieve treatment effects by modulating the rsFC of the amygdala.
Consistent with previous pilot studies (Manber et al., 2010; J. I.
Quah-Smith et al., 2005; Roschke et al., 2000; W. D. Wang et al.,ontgomery-Asberg depression rating scale; SDS, Self-rating depression scale.
Acupuncture mean (SD) Sham mean (SD)
18 18
44.5 (10.47) 43.78 (9.10)
22.94 (7.36) 22.83 (9.17)
5.44 (5.37) 14.06 (4.39)
47.833 (6.46) 47.44 (9.23)
26.83 (6.46) 34.94 (5.40)
Table 2
Regions showed signiﬁcantly increased resting-state functional connectivity between the amygdala and other brain regions after acupuncture treatment and sham treatment, controlling
for age as a covariate (voxel-wise, p b 0.005, uncorrected; cluster –wise, p b 0.05, FWE corrected). Abbreviations: AUC, acupuncture; sgACC, subgenual anterior cingulate cortex; pgACC,
pregenual anterior cingulate cortex; Para, parahippocampus; Pu, putamen.
Group Condition Seed Brain region Cluster size
mm3
Peak coordinate
(MNI space)
Peak Z-value
x y z
ACU plus ﬂuoxetine Post-treatment N pre-treatment Left amygdala Left sgACC/pgACC 278 −4 24 −20 3.78
Right amygdala Left Para/Pu 325 −28 −2 −12 3.86
Sham plus ﬂuoxetine Post-treatment b pre-treatment Right amygdala Left Para/Pu 359 −28 −2 −12 3.53
ACU plus ﬂuoxetine N Sham plus ﬂuoxetine Post-treatment N pre-treatment Left amygdala Left sgACC/pgACC 310 −14 28 −22 3.64
Right amygdala Left Para/Pu 352 −28 −2 −12 3.74
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ulation plus ﬂuoxetine could effectively reduce the symptoms of de-
pression. Interestingly, a paired t-test comparing pre and post-
treatment clinical outcomes also indicates that the symptoms in the
sham acupuncture plus ﬂuoxetine group signiﬁcantly decreased after
treatment (MADRS: p b 0.001; SDS: p b 0.001). We speculate that this
may be attributed to the treatment effect of ﬂuoxetine. The additional
effect of verum acupuncture demonstrated that acupuncture can be
combined with pharmacological treatment to achieve a greater thera-
peutic effect in MDD patients.
Antidepressants including ﬂuoxetine have been widely used as a
basic treatment for MDD (Gibbons et al., 2012). However, antidepres-
sant treatments may produce undesirable side effects and a delay in
the onset of therapeutic action (Arroll et al., 2005; Zhu et al., 2013). In
this study, we found that combining acupuncture with ﬂuoxetine can
produce greater improvement in MDD patients, which is consistent
with ﬁndings from previous studies investigating the combinative ef-
fects of acupuncture and other treatments (Duan et al., 2008; Y. Liu et
al., 2008; Roschke et al., 2000; Zhang et al., 2009; Zhu et al., 2013).
We found that after 8 weeks of treatment, the verum acupuncture
plus ﬂuoxetine treatment induced increased rsFC between the left
amygdala and sgACC/pgACC and between the right amygdala and left
putamen/parahippocampus. The sham acupuncture plus ﬂuoxetine
treatment induced decreased rsFC between the right amygdala and
left Pu/Para. A direct comparison between the two groups showed
that verum acupuncture plus ﬂuoxetine induced increased rsFC be-
tween the left amygdala and sgACC/pgACC and between the right
amygdala and Pu/Para compared with the sham group.
The sgACC, located underneath the genu of the corpus callosum, and
the pgACC, anterior to the genu of the corpus callosum, are both affec-
tive subdivisions of the anterior cingulate cortex (Felger et al., 2015;
Phillips et al., 2008; D. A. Pizzagalli, 2010). Speciﬁcally, the sgACC is im-
plicated in automatic behavioral control, and the pgACC is involved in
automatic attentional control based in part on their functional interac-
tion with limbic structures such as the amygdala (DeRubeis et al.,
2008; Drevets et al., 2008; Etkin et al., 2006; D. A. Pizzagalli, 2010;
Salvadore et al., 2010). Compared with healthy controls, MDD patients
show elevated activity in the amygdala and ACC areas in response to
negative stimuli (Felger et al., 2015; Salvadore et al., 2009), and they
also show abnormal reduced functional connectivity between the
amygdala and ACC (Anand et al., 2009; Felger et al., 2015; Lui et al.,
2011; Matthews et al., 2008; Veer et al., 2010). In addition, the region
also plays an important role in the self-regulation of pain such as place-
bo analgesia (Bingel et al., 2006; Eippert et al., 2009; Kong et al., 2006;
Kong et al., 2013; Petrovic et al., 2002) and acupuncture treatment of
chronic pain (X. Chen et al., 2014; X. Chen et al., 2015; Egorova et al.,
2015; Li et al., 2016a,b).
Both the sgACC and pgACC are considered as biomarkers to antide-
pressant response (Felger et al., 2015; Phillips et al., 2015; D. Pizzagalli
et al., 2001; D. A. Pizzagalli, 2011) or the target of deep brain stimulation
treatments (Felger et al., 2015; Hamani et al., 2010; Salvadore et al.,
2010) in MDD. For instance, previous studies found that antidepressant
treatments can increase the connectivity of the amygdala-sgACC duringthe perception of sad faces (C. H. Chen et al., 2008) and threatening
stimuli (Pezawas et al., 2005), and the connectivity of the pgACC-amyg-
dala can be used to predict antidepressant response to ketamine in a
working memory task context (Salvadore et al., 2010).
We also found increased rsFC between the right amygdala and a
cluster of brain regions including the left parahippocampus and puta-
men in the verum acupuncture group. The parahippocampus is associ-
ated with memory encoding and retrieval, and it is also linked to
emotional processing (Fu et al., 2007; Gosselin et al., 2006; Smith et
al., 2004; Van den Stock et al., 2012). The connectivity of the
parahippocampus with the amygdala has been proposed to mediate
contextual processing and emotion, thus facilitating emotion under-
standing and expectations of the environment (Aminoff et al., 2013;
LaBar & Cabeza, 2006). The altered rsFC between the amygdala and
parahippocampus is a powerful discrimination between MDD and
healthy controls (Zeng et al., 2012). Chen et al. (C. H. Chen et al.,
2008) found that after eight weeks of antidepressant treatment with
ﬂuoxetine hydrochloride, the coupling of the amygdala with the
parahippocampus was normalized to the levels of healthy controls.
The putamen is implicated in reward and motivation (Felger et al.,
2015; Fu et al., 2007; Robbins & Everitt, 1996). Previous fMRI studies
have found that individuals suffering from depression have lower acti-
vation in the putamen during the perception of happy faces (Critchley
et al., 2000; Lawrence et al., 2004; Phan et al., 2002). A similar study
(Hamilton & Gotlib, 2008) in adults withMDD using the bilateral amyg-
dala as seeds found that patients showed greater amygdala-putamen
connectivity compared with healthy controls during successful
encoding of negative emotional memories. With antidepressant treat-
ment, Chen et al. (C. H. Chen et al., 2008) observed increased coupling
of the amygdala and putamen in depressed subjects, which is consistent
with our results.
We also found that that acupuncture treatment produces different
effects on the left and right amygdala rsFC, and the changes of left amyg-
dala rsFC showed a negative association with depression symptoms. A
recent fMRI study (C. H. Chen et al., 2008) showed that antidepressant
treatments enhanced the connection between the left amygdala and
right lateral prefrontal cortex in response to unmasked negative faces
in depressed patients. Mccabe et al. (McCabe & Mishor, 2011) found re-
duced rsFC between the right amygdala and frontal cortex in healthy
subjects when they were administrated with the antidepressants
citalopram and reboxetine for seven days. We did not ﬁnd amygdala
and prefrontal cortex connectivity changes in our study. We speculate
this is mainly due to using a different treatment modality, method,
and patient population.
There are several limitations in our study. First, we used the total ana-
tomical structure of the amygdala as seeds, while amygdala subregional
structures, including the centromedial (stress), superﬁcial (socio-affec-
tive), and basolateral (learning and memory) amygdala are involved in
different emotion processing functions (Alarcon et al., 2015; Etkin et al.,
2004). Further focus on the rsFC of amygdala subregions is still needed.
Second, we only recruited female depressed patients to increase the ho-
mogeneity of the study, and thus, our external validity may only be ap-
plied to interpret the effects of acupuncture on female patients. More
751X. Wang et al. / NeuroImage: Clinical 12 (2016) 746–752study is needed to validate these ﬁndings in male patients. Finally, we
only focus on the added effect of acupuncture treatment to ﬁxed doses
of ﬂuoxetine in this study; there is no placebo ﬂuoxetine, which prevents
us from exploring the effect and mechanism of ﬂuoxetine as well as the
interaction between ﬂuoxetine and acupuncture.
In conclusion, we found that acupuncture plus ﬂuoxetine treatment
signiﬁcantly modulates the rsFC between the amygdala and sgACC/
pgACC in patientswithMDDcompared to shamacupuncture plus ﬂuox-
etine. This rsFC change is associated with clinical improvement. We be-
lieve thismodulation effectmay at least partly represent the underlying
mechanism of acupuncture treatment ofMDDwhen it is combinedwith
ﬂuoxetine.
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